Nicholas Bernards

ORCID: 0009-0007-7907-0317
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Lung Cancer Diagnosis and Treatment
  • Nanoplatforms for cancer theranostics
  • Photodynamic Therapy Research Studies
  • Tracheal and airway disorders
  • Radiopharmaceutical Chemistry and Applications
  • Photoacoustic and Ultrasonic Imaging
  • Venous Thromboembolism Diagnosis and Management
  • Mass Spectrometry Techniques and Applications
  • Medical Imaging Techniques and Applications
  • Ultrasound and Hyperthermia Applications
  • Cancer, Hypoxia, and Metabolism
  • Ultrasound in Clinical Applications
  • Spectroscopy Techniques in Biomedical and Chemical Research
  • Radiomics and Machine Learning in Medical Imaging
  • Medical Imaging and Pathology Studies
  • Cancer Research and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Lung Cancer Treatments and Mutations
  • Cancer Cells and Metastasis
  • Metabolomics and Mass Spectrometry Studies
  • Lung Cancer Research Studies
  • Airway Management and Intubation Techniques
  • Drug Transport and Resistance Mechanisms
  • Nanoparticle-Based Drug Delivery
  • Glioma Diagnosis and Treatment

Toronto General Hospital
2019-2024

University Health Network
2016-2024

Faculty of 1000 (United States)
2023

Health Net
2020-2023

RELX Group (United States)
2023

Princess Margaret Cancer Centre
2020

Toronto Public Health
2020

University of Toronto
2017-2019

West Virginia University
2017

PhytoCeutica (United States)
2017

Identification of necrosis in tumors is prognostic value treatment planning, as associated with aggressive forms cancer and unfavourable outcomes. To facilitate rapid detection Mass Spectrometry (MS), we report the lipid MS profile necrotic breast Desorption Electrospray Ionization (DESI-MS) imaging validated statistical analysis correlating pathology. This characterized by (1) presence ion m/z 572.48 [Cer(d34:1) + Cl]- which a ceramide absent from viable subregions; (2) absence 391.25...

10.1038/srep35374 article EN cc-by Scientific Reports 2016-10-13

Deposition of liposomal drugs into solid tumors is a potentially rate-limiting step for drug delivery and has substantial variability that may influence probability response.Tumor deposition shared mechanism therapeutics such single companion diagnostic agent have utility in predicting response to multiple nanomedicines.Methods: We describe the development, characterization preclinical proof-of-concept positron emission tomography (PET) agent, MM-DX-929, drug-free untargeted 100 nm PEGylated...

10.7150/thno.21670 article EN cc-by Theranostics 2018-01-01

A series of novel pyrazolo[1,5-a]pyrimidines, closely related to N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide (2, DPA-714), were synthesized and biologically in vitro evaluated for their potential bind the translocator protein 18 kDa (TSPO), a today recognized as an early biomarker neuroinflammatory processes. This is composed fluoroalkyl- fluoroalkynyl- analogues, prepared from common iodinated intermediate via Sonogashira coupling...

10.1021/acs.jmedchem.5b00932 article EN Journal of Medicinal Chemistry 2015-08-17

Spatially Targeted Mass Spectrometry (MS) analysis using survey scans with an imaging modality often requires consecutive tissue slices, because of the damage during scan or due to incompatible sample preparation requirements between and MS. We report two spatially targeted MS workflows based on polarized light guidance that use same for analysis. The first workflow is applicable thin-slice analysis, uses transmission-polarimetry-guided Desorption ElectroSpray Ionization (DESI-MS),...

10.1038/s41598-017-00272-y article EN cc-by Scientific Reports 2017-03-22

Nanoscale perfluorocarbon (PFC) droplets have enormous potential as clinical theranostic agents. They are biocompatible and currently used

10.7150/ntno.29908 article EN cc-by-nc Nanotheranostics 2019-01-01

The purpose of the study was to validate [18F]DPA-714, a translocator protein (TSPO) 18 kDa radioligand, as probe non-invasively quantify inflammatory state in bowel disease (IBD) animal models.Quantitative positron emission tomography (PET) imaging intestinal inflammation conducted with 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) glucose metabolism surrogate marker and [18F]DPA-714 ligand TSPO, on two IBD models. first model induced using dextran sodium sulfate (DSS), creating global colon....

10.1007/s11307-014-0765-9 article EN cc-by Molecular Imaging and Biology 2014-07-11

Integration between a hand-held mass spectrometry desorption probe based on picosecond infrared laser technology (PIRL-MS) and an optical surgical tracking system demonstrates <italic>in situ</italic> tissue pathology from point-sampled data.

10.1039/d0sc02241a article EN cc-by-nc Chemical Science 2020-01-01

We describe here a simple and versatile route for the preparation of tridentate ligand that not only provides stable interactions with colloidal semiconductor nanocrystals (quantum dots, QDs) but also makes them water soluble. The designed incorporates biocompatible solubilizing polyethylene glycol (PEG) chain connected to thiol motif improved affinity towards QDs surface. Stability experiments revealed better resistance various drastic conditions compared classical dihydrolipoic-based...

10.1039/c2sc21113k article EN Chemical Science 2012-10-12

Rheumatoid arthritis (RA) is a chronic disease, affecting 0.5 to 1% of adults in industrialized countries, which systemic inflammation and synovitis drive joint destruction. [18F]DPA-714 specific tracer the 18 kDa translocator protein (TSPO), overexpressed on activated macrophages, proposed as biomarker neuroinflammation. Today, diagnosis patients with early inflammatory limited by poor sensitivity specificity. The present study aims investigate potential monitor vivo processes at...

10.1186/ar4508 article EN cc-by Arthritis Research & Therapy 2014-01-01

Triple negative breast cancer (TNBC) represents a significant therapeutic challenge due to its highly aggressive nature and lack of effective treatment options. Liposomal irinotecan (nal-IRI, ONIVYDE) was approved in 2015 (by the Food Drug Administration, European Medicines Agency, Therapeutic Goods Administration) is topoisomerase inhibitor indicated, combination with fluorouracil leucovorin, for patients metastatic adenocarcinoma pancreas after disease progression following...

10.1021/acs.molpharmaceut.8b00540 article EN Molecular Pharmaceutics 2018-07-30

Abstract While photodynamic therapy (PDT) can induce acute inflammation in the irradiated tumor site, a sustained systemic, adaptive immune response is desirable, as it may control growth of nonirradiated distant disease. Previously, we developed porphyrin lipoprotein (PLP), ∼20 nm nanoparticle photosensitizer, and observed that not only efficiently eradicated primary VX2 buccal carcinomas rabbits, but also induced regression metastases draining lymph node. We hypothesized PLP-mediated PDT...

10.1515/nanoph-2021-0241 article EN cc-by Nanophotonics 2021-08-03

Clinical studies implying the sunitinib multi-kinase inhibitor have led to disappointing results for breast cancer care but mostly focused on HER2-negative subtypes. Preclinical researches involving this drug concern Triple Negative Breast Cancer (TNBC) murine models. Here, we explored therapeutic efficacy of a PyMT-derived transplanted model classified as luminal B (HER2-positive) and monitored response treatment using both in vivo ex approaches.Tumour-induced animals were treated 9 (n = 7)...

10.1186/s12885-015-1540-2 article EN cc-by BMC Cancer 2015-07-21

Abstract DPA‐C5yne, the lead compound of a novel series DPA‐714 derivatives in which fluoroethoxy chain linked to phenylpyrazolopyrimidine scaffold has been replaced by fluoroalkyn‐1‐yl moiety, is high affinity (K i : 0.35 nM) and selective ligand targeting translocator protein 18 kDa. In present work, DPA‐C5yne was labelled with no‐carrier‐added [ F]fluoride based on one‐step tosyloxy‐for‐fluorine nucleophilic substitution reaction, purified cartridge HPLC, formulated as an i.v. injectable...

10.1002/jlcr.3199 article EN Journal of Labelled Compounds and Radiopharmaceuticals 2014-04-24

Purpose Diagnosis and resection of indeterminate pulmonary nodules (IPNs) is a growing challenge with increased utilization chest computed tomography. Photoacoustic (PA) -guided surgical local injection indocyanine green (ICG) may have utility for IPNs that are suspicious lung cancer. This preclinical study explores the potential PA imaging (PAI) to detect ICG-labeled tumors. Materials methods ICG uptake by H460 cancer cells was evaluated in vitro. A phantom performed analyze signal...

10.1371/journal.pone.0231488 article EN cc-by PLoS ONE 2020-04-21

Abstract Objective. Laser interstitial thermal therapy (LITT) is an evolving hyperthermia-based technology that may offer a minimally invasive alternative to inoperable lung cancer. LITT of perivascular targets challenged by higher risk disease recurrence due vascular heat sinks, as well damage these structures. The objective this work examine the impact multiple vessel parameters on efficacy treatment and integrity wall in LITT. Approach. A finite element model used role proximity, flow...

10.1088/2057-1976/acc319 article EN cc-by Biomedical Physics & Engineering Express 2023-03-10

Conventional flexible bronchoscopy has not achieved the high diagnostic yield for intrapulmonary lesions as seen with image-guided transthoracic biopsy. A thin convex probe endobronchial ultrasound bronchoscope (TCP-EBUS) a 5.9-mm tip was designed to improve peripheral access over conventional EBUS bronchoscopes facilitate real-time sampling of under guidance.TCP-EBUS inserted into distal airways ex-vivo human lungs assess bronchial accessibility relative clinically available bronchoscopes....

10.21037/tlcr-22-120 article EN Translational Lung Cancer Research 2022-07-01

ObjectiveSevere pulmonary embolism is often managed with thrombolysis. We sought to determine whether endobronchial ultrasound (EBUS)-guided transbronchial thrombolysis remained effective at lower alteplase doses, the goal of minimizing potential bleeding risk.MethodsYorkshire pigs were anesthetized and ventilated. Preformed autologous blood clots administered into bilateral arteries via EBUS-guided injection. After documenting baseline clot sizes, was injected using a 25-gauge needle...

10.1016/j.jtcvs.2022.08.044 article EN cc-by-nc-nd Journal of Thoracic and Cardiovascular Surgery 2022-09-14

Purpose To evaluate CF800, a novel lipid-based liposomal nanoparticle that co-encapsulates indocyanine green (ICG) and iohexol, for CT imaging of pulmonary vasculature in minimally-invasive thoracic surgery planning. Methods CF800 was intravenously administered to 7 healthy rabbits. In vivo performed 15 min post-injection, with subset animals imaged at 24h, 48h, 72h post injection. Signal-to-background ratios (SBR) were calculated the inferior vena cava compared across time-points. A similar...

10.1371/journal.pone.0209501 article EN cc-by PLoS ONE 2019-01-17

Endobronchial ultrasound-guided transbronchial needle injection (EBUS-TBNI) may effectively treat acute pulmonary embolisms (PEs). Here, we assessed the effectiveness of clot dissolution and safety tissue plasminogen activator (t-PA) using EBUS-TBNI in a 1-week survival study porcine PE model.Six pigs with bilateral PEs were used: 3 for t-PA (TBNI group) systemic administration (systemic group). Once created, each 25 mg (a total 50 t-PA) 100 was performed on day 1. Hemodynamic parameters,...

10.1016/j.xjtc.2023.09.005 article EN cc-by-nc-nd JTCVS Techniques 2023-09-20

Photodynamic therapy (PDT) and photothermal (PTT) show promise as cancer treatments, but challenges in generating large ablative volumes for deep-seated tumours persist. Using simulations, this study investigates combined PDT PTT to increase treatment volumes, including the impact of a temperature-dependent dose on volume radius. A finite-element model, using open-source SfePy package, was developed simulate interstitial photodynamic treatments. Results compared an additive model with...

10.1016/j.pdpdt.2023.103949 article EN cc-by-nc-nd Photodiagnosis and Photodynamic Therapy 2023-12-01
Coming Soon ...